Actinium Pharmaceuticals, Inc. (ATNM) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 90K | 0 | 0 | 0 | 0 | 0 | 0 | 81K | 0 | 0 | 0 | 0 | 45K | 45K | 940K | 23K | 233K | 266K |
| Revenue Growth % | - | - | - | - | - | -100% | - | - | - | - | -100% | -100% | -100% | -100% | -80.69% | -83.08% | 51.13% | - | - | - |
| Cost of Goods Sold | 220K | -615K | 0 | 0 | 0 | 204K | 202K | 189K | 216K | 199K | 200K | 209K | 0 | 161K | 221K | 180K | 137K | 137K | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | 245.68% | - | - | - | - | 491.11% | 400% | 14.57% | 595.65% | - | - |
| Gross Profit | -220K | 615K | 90K | 0 | 0 | -204K | -202K | -189K | -216K | -118K | -200K | -209K | 0 | -161K | -176K | -135K | 803K | -114K | 233K | 266K |
| Gross Margin % | - | - | 100% | - | - | - | - | - | - | -145.68% | - | - | - | - | -391.11% | -300% | 85.43% | -495.65% | 100% | 100% |
| Gross Profit Growth % | - | 401.47% | 144.55% | 100% | 100% | -72.88% | -1% | 9.57% | - | 26.71% | -13.64% | -54.81% | -100% | -41.23% | -175.54% | -150.75% | 29.1% | - | - | - |
| Operating Expenses | 5.68M | 7.03M | 5.78M | 7.5M | 16.64M | 7.3M | 12.4M | 12.23M | 9.38M | 10.22M | 14.15M | 15.43M | 11.58M | 11.13M | 9.62M | 7.71M | 5.97M | 7.93M | 6.7M | 5.34M |
| OpEx % of Revenue | - | - | 6424.44% | - | - | - | - | - | - | 12623.46% | - | - | - | - | 21384.44% | 17144.44% | 634.79% | 34495.65% | 2876.39% | 2007.89% |
| Selling, General & Admin | 1.7M | 2.12M | 1.53M | 2.62M | 8.94M | 2.69M | 2.83M | 3.59M | 2.96M | 2.31M | 2.73M | 4.56M | 3.73M | 3.96M | 3.07M | 3.23M | 1.74M | 2.65M | 1.99M | 1.71M |
| SG&A % of Revenue | - | - | 1704.44% | - | - | - | - | - | - | 2846.91% | - | - | - | - | 6828.89% | 7184.44% | 184.57% | 11543.48% | 855.79% | 642.86% |
| Research & Development | 4.2M | 4.91M | 4.25M | 4.88M | 7.7M | 4.61M | 9.57M | 8.64M | 6.42M | 7.92M | 11.42M | 10.87M | 7.85M | 7.17M | 6.55M | 4.48M | 4.23M | 5.28M | 4.71M | 3.63M |
| R&D % of Revenue | - | - | 4720% | - | - | - | - | - | - | 9776.54% | - | - | - | - | 14555.56% | 9960% | 450.21% | 22952.17% | 2020.6% | 1365.04% |
| Other Operating Expenses | -220K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.9M | -6.41M | -5.69M | -7.5M | -16.64M | -7.5M | -12.6M | -12.42M | -9.6M | -10.34M | -14.35M | -15.64M | -11.58M | -11.29M | -9.8M | -7.85M | -5.16M | -8.05M | -6.47M | -5.08M |
| Operating Margin % | - | - | -6324.44% | - | - | - | - | - | - | -12769.14% | - | - | - | - | -21775.56% | -17444.44% | -549.36% | -34991.3% | -2776.39% | -1907.89% |
| Operating Income Growth % | 64.52% | 14.54% | 54.83% | 39.58% | -73.37% | 27.44% | 12.19% | 20.61% | 17.15% | 8.4% | -46.45% | -99.26% | -124.32% | -40.3% | -51.48% | -54.68% | 3.87% | -25.07% | -15.25% | -8.86% |
| EBITDA | -5.68M | -6.21M | -5.49M | -7.3M | -16.43M | -7.3M | -12.4M | -12.23M | -9.38M | -10.14M | -14.15M | -15.43M | -11.4M | -11.13M | -9.58M | -7.67M | -5.03M | -7.91M | -6.34M | -4.95M |
| EBITDA Margin % | - | - | -6095.56% | - | - | - | - | - | - | -12523.46% | - | - | - | - | -21284.44% | -17044.44% | -534.79% | -34395.65% | -2719.31% | -1859.4% |
| EBITDA Growth % | 65.42% | 14.97% | 55.75% | 40.31% | -75.17% | 28.03% | 12.38% | 20.76% | 17.72% | 8.86% | -47.74% | -101.21% | -126.82% | -40.69% | -51.17% | -55.07% | 4.19% | -25.27% | -15.16% | -8.61% |
| D&A (Non-Cash Add-back) | 220K | 206K | 206K | 204K | 205K | 204K | 202K | 189K | 216K | 199K | 200K | 209K | 182K | 161K | 221K | 180K | 137K | 137K | 133K | 129K |
| EBIT | -5.9M | -6.41M | -5.69M | -7.5M | -16.64M | -6.65M | -11.57M | -11.35M | -9.6M | -10.34M | -13.28M | -15.18M | -11.58M | -10.65M | -9.47M | -7.77M | -5.13M | -8.01M | -6.47M | -5.08M |
| Net Interest Income | 381K | -1.89M | 561K | 625K | 700K | 853K | 1.03M | 1.06M | 927K | 1.02M | 1.07M | 461K | 547K | 644K | 325K | 83K | 35K | 38K | 46K | 54K |
| Interest Income | 381K | -1.89M | 561K | 625K | 700K | 853K | 1.03M | 1.06M | 927K | 1.02M | 1.07M | 461K | 547K | 644K | 325K | 83K | 35K | 38K | 46K | 54K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 381K | 474K | 561K | 625K | 700K | 853K | 1.03M | 1.06M | 927K | 1.02M | 1.07M | 461K | 547K | 644K | 325K | 83K | 35K | 38K | 46K | 54K |
| Pretax Income | -5.52M | -5.94M | -5.13M | -6.88M | -15.94M | -6.65M | -11.57M | -11.35M | -8.67M | -9.32M | -13.28M | -15.18M | -11.04M | -10.65M | -9.47M | -7.77M | -5.13M | -8.01M | -6.42M | -5.02M |
| Pretax Margin % | - | - | -5701.11% | - | - | - | - | - | - | -11511.11% | - | - | - | - | -21053.33% | -17260% | -545.64% | -34826.09% | -2756.65% | -1887.59% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -5.52M | -5.94M | -5.13M | -6.88M | -15.94M | -6.65M | -11.57M | -11.35M | -8.67M | -9.32M | -13.28M | -15.18M | -11.04M | -10.65M | -9.47M | -7.77M | -5.13M | -8.01M | -6.42M | -5.02M |
| Net Margin % | - | - | -5701.11% | - | - | - | - | - | - | -11511.11% | - | - | - | - | -21053.33% | -17260% | -545.64% | -34826.09% | -2756.65% | -1887.59% |
| Net Income Growth % | 65.35% | 10.7% | 55.64% | 39.42% | -83.83% | 28.66% | 12.87% | 25.22% | 21.45% | 12.43% | -40.13% | -95.46% | -115.19% | -32.92% | -47.5% | -54.69% | 3.59% | -25.55% | -15.94% | -8.56% |
| Net Income (Continuing) | -5.52M | -5.94M | -5.13M | -6.88M | -15.94M | -6.65M | -11.57M | -11.35M | -8.67M | -9.32M | -13.28M | -15.18M | -11.04M | -10.65M | -9.47M | -7.77M | -5.13M | -8.01M | -6.42M | -5.02M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.18 | -0.19 | -0.16 | -0.22 | -0.51 | -0.21 | -0.37 | -0.38 | -0.31 | -0.34 | -0.49 | -0.58 | -0.43 | -0.39 | -0.36 | -0.33 | -0.23 | -0.37 | -0.30 | -0.25 |
| EPS Growth % | 64.71% | 9.52% | 56.76% | 42.11% | -64.52% | 38.24% | 24.49% | 34.48% | 27.91% | 12.82% | -36.11% | -75.76% | -86.96% | -5.41% | -20% | -32% | 20.69% | -5.71% | 16.67% | 39.02% |
| EPS (Basic) | -0.18 | -0.19 | -0.16 | -0.22 | -0.51 | -0.21 | -0.37 | -0.38 | -0.31 | -0.34 | -0.49 | -0.58 | -0.43 | -0.39 | -0.37 | -0.33 | -0.23 | -0.37 | -0.30 | -0.25 |
| Diluted Shares Outstanding | 31.24M | 31.2M | 31.2M | 31.2M | 31.2M | 31.2M | 31.07M | 30.1M | 27.89M | 27.63M | 27.06M | 26.22M | 25.7M | 25.68M | 25.16M | 23.73M | 22.14M | 21.54M | 21.54M | 20.23M |
| Basic Shares Outstanding | 31.24M | 31.2M | 31.2M | 31.2M | 31.2M | 31.2M | 31.07M | 30.1M | 27.89M | 27.63M | 27.06M | 26.22M | 25.7M | 25.68M | 24.93M | 23.73M | 22.14M | 21.54M | 21.54M | 20.23M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |